UCB BIOPHARMA
Personen
6
Standorte
3
Veröffentlichungen
36
Unternehmensprofil
Gründungsdatum
24. Dezember 2013
Letztes Bilanzjahr
2024
Rechtsform
Besloten Vennootschap
Unternehmenstyp
Rechtspersoon
Aktivität
72101 - Speur- en ontwikkelingswerk op biotechnologisch gebied
Unternehmensalter
13 Jahre
Kontaktdaten
Unlock direct contact points, registry address detail, and website links for UCB BIOPHARMA.
Unlock Contact Details
Reveal email, phone, website, and full registry contact information.
Create Free AccountHistorische Finanzdaten
| KPI | 2024 | 2023 | 2022 |
|---|---|---|---|
| Umsatz | 3.560.535.341 € (+36.0%) | 2.617.131.393 € (-8.2%) | 2.850.940.162 € (-13.4%) |
| Bruttomarge | - | - | - |
| Gewinn | 8.462.666 € (+101.3%) | -676.933.225 € (-30.3%) | -519.501.153 € (-1.8%) |
| EBITDA | 1.718.143.605 € (+81.3%) | 947.902.597 € (-20.0%) | 1.185.494.139 € (-23.2%) |
| Eigenkapital | 1.101.860.673 € (+275.6%) | 293.398.007 € (-69.8%) | 970.331.232 € (+98.1%) |
| Schulden | 4.678.167.657 € (+7.7%) | 4.345.017.091 € (+15.0%) | 3.779.052.613 € (-28.5%) |
| Gesamtkapital | 6.244.745.945 € (+21.6%) | 5.133.880.523 € (-3.2%) | 5.305.267.743 € (-17.3%) |
| Barmittel | 25.879.024 € (-70.3%) | 87.146.179 € (-0.3%) | 87.406.203 € (-64.3%) |
| Vollzeitäquivalente (FTE) | 1.317,9 (+3.8%) | 1.269,4 (+0.1%) | 1.267,9 (+2.7%) |
Unlock Full History
Create a free account to access up to 10 years of historical financial data for UCB BIOPHARMA.
Create Free AccountFinanzielle Gesundheit
Ratio-level insight derived from the latest company and balance sheet data.
Current Ratio
0,8x
(+29.8%)
Quick Ratio
0,8x
(+29.8%)
Solvency
17,6%
(+208.7%)
Debt / Equity
4,2x
Unlock Advanced Metrics
Access the full ratio deck, benchmarking signals, and deeper profitability diagnostics.
Create Free AccountStandorte & Präsenz
Establishment
AdresseResearchdreef 60, 1070 Anderlecht, Belgium
Establishment
AdresseChemin du Foriest /, 1420 Braine-l'Alleud, Belgium
Establishment
AdresseGaston Geenslaan 14, 3001 Leuven, Belgium
Unternehmensnetzwerk
First-level relations linked directly to UCB BIOPHARMA. Unlock second-level relations for deeper graph exploration.
UCB BIOPHARMA
Aktiv
-
Alistair HENRY
Incoming link
Administrator Natural -
Denelle J. WAYNICK JOHNSON
Incoming link
Administrator Natural -
Dhavalkumar PATEL
Incoming link
Administrator Natural -
Jean-Luc FLEURIAL
Incoming link
Administrator Natural -
Sandrine DUFOUR
Incoming link
Administrator Natural -
William SILBEY
Incoming link
Administrator Natural - ExeVir Bio
Incoming link
Participating Interest - SYNDESI THERAPEUTICS
Incoming link
Participating Interest - UCB PHARMA
Outgoing link
Participating Interest - UCB PHARMA
Incoming link
Shareholder Entity
Unlock Second-Level Relations
Expand beyond direct links to see second-level entities, people, and cross-company paths.
Free Sign UpVeröffentlichungen im Belgischen Staatsblatt
Management & Schlüsselpersonen
Unlock linked people, governance roles, and enriched demographic signals associated with UCB BIOPHARMA.
Management Profiles
Unlock directors, managers, role history, plus inferred gender and age where available.
Create Free Account